Tags : Veyonda

Pharma

Noxopharm Collaborates with GenesisCare to Bring Combination Regimen of Veyonda

Shots: The collaboration offers a compassionate access program to make the combination therapy of Veyonda & 7Lu-PSMA available to the patients suffering from mCRPC, being treated with theranostics in Australia The combination regimen is currently being evaluated in clinical studies in patients with advanced mCRPC, demonstrating improvement in response rate with mOS (17.1mos.) and a […]Read More